M Holdings Securities, Inc. Biocryst Pharmaceuticals Inc Transaction History

M Holdings Securities, Inc.

  • $398 Million
  • Q3 2024

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2022

May 24, 2022
SELL
$11.56 - $19.76 $184,127 - $314,737
-15,928 Closed
0 $0
Q2 2021

Aug 19, 2021
BUY
$9.5 - $17.24 $17,803 - $32,307
1,874 Added 13.33%
15,928 $252,000
Q1 2021

May 12, 2021
BUY
$7.37 - $13.61 $103,577 - $191,274
14,054 New
14,054 $143,000

Others Institutions Holding BCRX

# of Institutions
280
Shares Held
172M
Call Options Held
625K
Put Options Held
739K
View Full List

About BIOCRYST PHARMACEUTICALS INC

BCRX Quotes by TradingView
  • Ticker BCRX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 185,944,992
  • Market Cap $1.39B
  • Description
  • BioCryst Pharmaceuticals, Inc., a biotechnology company, discovers novel, oral, and small-molecule medicines. The company markets peramivir injection, an intravenous neuraminidase inhibitor for the treatment of acute uncomplicated influenza under the RAPIVAB, RAPIACTA, and PERAMIFLU names; and ORLADEYO, an oral serine protease inhibitor to treat...
More about BCRX
Track This Portfolio

Track M Holdings Securities, Inc. Portfolio

Follow M Holdings Securities, Inc. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of M Holdings Securities, Inc., based on Form 13F filings with the SEC.

News

Stay updated on M Holdings Securities, Inc. with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email